Literature DB >> 10219827

Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide.

C Pisano1, D Grandi, G Morini, G Coppelli, L Vesci, P Lo Giudice, S Pace, L Pacifici, A Longo, G Coruzzi, P Carminati.   

Abstract

The effect of the nonsteroidal antiinflammatory drug (NSAID) amtolmetin guacyl (AMG) on the gastric mucosa was studied in the rat by means of histological and functional techniques. AMG administered at 50-300 mg/kg intragastrically was virtually devoid of gastrolesive properties after either acute or repeated treatment. By contrast, its metabolite, tolmetin (TOL, 15-60 mg/kg, intragastrically) caused dose-dependent gastric damage after both treatments. Light and electron microscopy revealed that AMG induced minimal changes in the surface epithelium layer, without signs of vasocongestion or leukocytes adherence. AMG (50 mg/kg intragastrically) did not change basal gastric potential difference (PD), whereas acetylsalicylic acid and ibuprofen induced falls in PD of 22 and 27 mV, respectively. AMG (50 mg/kg intragastrically) reduced by 60% the fall in PD induced by 50% ethanol; this inhibition was dependent on the incubation time, and was maximal when AMG was given 4 hr before ethanol. AMG (100 mg/kg intragastrically) induced an increase in NO synthase type 2 (NOS2) activity, which was significantly different from control values, when AMG was administered 4 hr before the test. The metabolites of AMG, tolmetin, MED 5, and guaiacol were ineffective. Pharmacokinetic analysis of the residence time of AMG in the different areas of the gastrointestinal tract, revealed that AMG remains in the gastrointestinal tract at least for 4 hr, the time necessary for a maximal induction of NOS2 and for maximal protection against ethanol-induced damage. In conclusion, these data indicate that the nonsteroidal antiinflammatory drug amtolmetin guacyl is devoid of gastrolesive properties; this gastro-sparing effect seems to involve the production of nitric oxide, which can counteract the damaging effects due to prostaglandin inhibition. The presence in the stomach of the native molecule of amtolmetin guacyl seems to be necessary for the protective effect observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219827     DOI: 10.1023/a:1026653623516

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa.

Authors:  J F Brown; B L Tepperman; P J Hanson; B J Whittle; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

2.  Pharmacological properties and toxicology of MED-15, a prodrug of tolmetin.

Authors:  A Caruso; V M Cutuli; E De Bernardis; G Attaguile; M Amico-Roxas
Journal:  Drugs Exp Clin Res       Date:  1992

Review 3.  Cyclooxygenase-2: regulation and relevance in inflammation.

Authors:  J A Mitchell; S Larkin; T J Williams
Journal:  Biochem Pharmacol       Date:  1995-11-09       Impact factor: 5.858

4.  Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes.

Authors:  G M Rubanyi; E H Ho; E H Cantor; W C Lumma; L H Botelho
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

5.  Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat.

Authors:  B J Whittle; J Lopez-Belmonte; S Moncada
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

6.  A new technique for continuous measurement and recording of gastric potential difference in the rat: evaluation of NSAID-induced gastric mucosal damage.

Authors:  C Scarpignato; C Corradi; M A Gandolfi; J P Galmiche
Journal:  J Pharmacol Toxicol Methods       Date:  1995-10       Impact factor: 1.950

7.  Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.

Authors:  J L Wallace; C M Keenan; D N Granger
Journal:  Am J Physiol       Date:  1990-09

8.  Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.

Authors:  S Kato; M Kitamura; R P Korolkiewicz; K Takeuchi
Journal:  Br J Pharmacol       Date:  1998-03       Impact factor: 8.739

Review 9.  Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: pathogenesis and mechanisms re-examined.

Authors:  J L Wallace
Journal:  Scand J Gastroenterol Suppl       Date:  1992

10.  Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.

Authors:  E Tubaro; L Belogi; C M Mezzadri; L Ruco; A Stopacciaro
Journal:  Arzneimittelforschung       Date:  1995-12
View more
  3 in total

1.  Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage.

Authors:  G Riezzo; M Chiloiro; S Montanaro
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

2.  Gastroprotective effect and mechanism of amtolmetin guacyl in mice.

Authors:  Yuan-Hai Li; Jun Li; Yan Huang; Xiong-Wen Lu; Yong Jin
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

3.  Amtolmetin: A Reappraisal of NSAID with Gastroprotection.

Authors:  Amit Garg; Ahsan Shoeb; Latha Subramanya Moodahadu; Akhilesh Sharma; Arul Gandhi; Shyam Akku
Journal:  Arthritis       Date:  2016-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.